Insulin-to-HDL-C Ratio as a Simple and Reliable Surrogate Marker of Metabolic dysfunction-associated steatotic liver disease Prevalence, Steatosis Severity, and Metabolic Burden: A Cross-Sectional Comparison with Established Insulin Resistance Indices

The liver is the body's chemical processing plant, filtering blood and managing energy. For decades, doctors have known that when this organ becomes clogged with fat, it signals a deeper trouble: a condition where the body struggles to use insulin, a hormone that helps cells absorb sugar. This struggle, known as insulin resistance, is the engine behind a growing wave of liver disease now called metabolic dysfunction-associated steatotic liver disease, or MASLD. Unlike older terms that focused only on alcohol use, this modern definition recognizes that the liver often fails because of a broader metabolic breakdown involving weight, blood sugar, and cholesterol. The challenge for doctors has been finding a simple way to spot this problem early, before it causes permanent damage, using tests that are already part of a standard checkup.

A team of researchers at Gangnam Severance Hospital in South Korea set out to solve this puzzle by looking at a specific combination of numbers found in routine blood work. They focused on two values that are easy to measure: the amount of insulin in the blood and the level of high-density lipoprotein cholesterol, often called "good" cholesterol. In a healthy body, insulin works efficiently, and good cholesterol levels remain steady. However, as the body begins to resist insulin, the pancreas pumps out more of the hormone to compensate, and the levels of good cholesterol tend to drop. The researchers wondered if the ratio between these two numbers—the amount of insulin divided by the amount of good cholesterol—could serve as a single, powerful signal for liver fat.

To test this idea, the team analyzed data from 1,735 adults who had undergone comprehensive health screenings. These were everyday people, not patients already in treatment for diabetes, ensuring the results reflected the general population. The researchers excluded anyone taking medication for diabetes to avoid skewing the insulin readings. Each participant had their liver examined with an ultrasound, a painless imaging test that uses sound waves to see inside the body. This allowed the doctors to see not just if fat was present, but how much was there, grading the condition from none to severe. The team then grouped the participants based on their insulin-to-HDL ratio, creating four categories from the lowest values to the highest.

The results revealed a clear and steady pattern. As the ratio of insulin to good cholesterol increased, the likelihood of having fatty liver disease rose sharply. In the group with the lowest ratios, only about 14 percent had the condition. In the group with the highest ratios, that number jumped to nearly 67 percent. This trend held true regardless of whether the participants were men or women, and it was consistent across different body types. The researchers found that people in the highest group were nearly five times more likely to have the disease than those in the lowest group, even after accounting for age, weight, exercise habits, and other health factors like high blood pressure or diabetes.

Beyond just detecting the presence of the disease, the ratio also seemed to track with how bad the condition was. Participants with higher ratios were more likely to have moderate or severe fat accumulation in their liver, rather than just mild cases. This suggests the number is not just a simple on-off switch but a gauge that reflects the growing burden of fat in the organ. The study also looked at how well this new ratio compared to other established methods doctors use to measure insulin resistance, such as the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) or the triglyceride-glucose index. The insulin-to-HDL ratio performed better than HDL-C, fasting insulin, and HOMA-IR, while performing comparably to the TyG index and TG/HDL-C ratio. It was particularly effective at identifying the disease in people who did not yet have obvious signs of metabolic trouble, such as obesity or high blood pressure, suggesting it could catch the problem earlier than current methods.

The researchers noted that this relationship was especially strong in people who did not have high blood pressure, hinting that the ratio might be a sensitive early warning system before other symptoms appear. While the study was cross-sectional, meaning it captured a snapshot in time rather than following people over years, the consistency of the findings across such a large group gives the results significant weight. The team concluded that this simple calculation, derived from two standard blood tests, offers a reliable and biologically meaningful way to assess the risk of fatty liver disease. By combining the story of insulin resistance with the story of cholesterol, this single number provides a clearer view of the metabolic health of the liver, potentially allowing doctors to intervene sooner in the journey toward better health.